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The transcriptome of Euglena gracilis reveals
unexpected metabolic capabilities for
carbohydrate and natural product biochemistry†
Ellis C. O’Neill,a Martin Trick,b Lionel Hill,c Martin Rejzek,a Renata G. Dusi,d
Chris J. Hamilton,d Paul V. Zimba,e Bernard Henrissatfgh and Robert A. Field*a
Euglena gracilis is a highly complex alga belonging to the green plant line that shows characteristics of
both plants and animals, while in evolutionary terms it is most closely related to the protozoan parasites
Trypanosoma and Leishmania. This well-studied organism has long been known as a rich source of
vitamins A, C and E, as well as amino acids that are essential for the human diet. Here we present
de novo transcriptome sequencing and preliminary analysis, providing a basis for the molecular and
functional genomics studies that will be required to direct metabolic engineering efforts aimed at
enhancing the quality and quantity of high value products from E. gracilis. The transcriptome contains
over 30000 protein-encoding genes, supporting metabolic pathways for lipids, amino acids, carbohydrates
and vitamins, along with capabilities for polyketide and non-ribosomal peptide biosynthesis. The metabolic and
environmental robustness of Euglena is supported by a substantial capacity for responding to biotic and abiotic
stress: it has the capacity to deploy three separate pathways for vitamin C (ascorbate) production, as well as
producing vitamin E (a-tocopherol) and, in addition to glutathione, the redox-active thiols nor-trypanothione
and ovothiol.
Introduction
Euglenoids are abundant algae, typically found in freshwater
rich in organics, where they can be so populous as to give their
characteristic colour to the water, such as the verdant green
Euglena viridis or blood red Euglena sanguinea. They were first
documented1 by van Leeuwenhoek in his 1674 letter to the
Royal Society,2 although Harris is usually credited with the first
description of this species.3 These large unicellular organisms
(Fig. 1A), up to 100 mm in length, possess an eye spot photo-
receptor, enabling Euglena to perceive light and swim towards
it using its single flagellum for motility or by a unique so-called
euglenoid locomotion. Euglena exhibits mixotrophy, switching
between photosynthesis, absorbing nutrients/small metabolites,
and engulfing other eukaryotes and bacteria as the opportunity
or need arises.
Euglena gracilis has been extensively investigated for the
production of vitamins A, C, E,4 and essential amino acids
and is also a good source of polyunsaturated fatty acids.5
Although a photosynthetic organism, Euglena does not produce
a typical a-1,4/6-glucan, such as starch. Instead, when grown
aerobically in light it produces an insoluble b-1,3-glucan, para-
mylon,6 contributing up to ca. 85% of its’ dry weight. This
glycopolymer shows immune stimulatory properties7 and is
reported to have anti-HIV8 effects. In contrast, under anaerobic
conditions wax esters9,10 comprise over 50% of the dry weight
of some strains of Euglena. These compounds are produced
even under adverse conditions such as those encountered in
acid mine drains,11 which suggests potential for the use of this
taxa in waste water management12 and/or the production of
biodiesel. Euglenoids are physiologically very flexible, resulting
in their use in many diverse scientific fields, including: as
a reporter for vitamin B12 production13 and for the clinical
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analysis of B12 in human serum;14 to study the ecotoxicity of
zinc oxide nanoparticles;15 in a neurocomputer based on their
motion in a micro aquarium;16 and for the intracellular bio-
synthesis of ferri-hydrite17 and silver18 nanoparticles. Euglena
behaviour has been studied using zero gravity flight19 and the
nature of their active gravitaxis mechanisms has been investi-
gated under varying acceleration conditions aboard the space
shuttle Columbia.20
Phylogenetically, Euglena are unlike other rigorously studied
algae in that their closest neighbours are the human pathogenic
protozoa Trypanosoma and Leishmania (Fig. 1B). Their unique
phylogenetic position and the ease with which Euglena can be
cultured has made them one of the most highly studied eukar-
yotes, playing a pivotal role in the development of cell biology and
biochemistry, a topic that is thoroughly reviewed in The Biology
of Euglena by Buetow21–24 and A Color Atlas of Photosynthetic
Euglenoids by Ciugulea and Triemer.25 However, despite the well-
established potential for biotechnology applications for eugle-
noids, we know little about their genetically-encoded metabolic
capacity. Sequencing the genome of Euglena has proved proble-
matic due to its size and complexity, which has arisen from a
series of endosymbiotic events during its evolution.26,27 Aside
from typical eukaryotic epigenetic modifications, including DNA
methylation and histone acetylation, the genome of Euglena also
contains the modified nucleotide Base J (glucosylated hydroxy-
thymidine), also found in kinetoplastids,28 which complicates DNA
sequencing. Additionally Euglena has the ability to extensively
process mRNA during transcription,29 altering the sequences
before translation; hence the proteome would be difficult to predict
from its genome. Avoiding the complications of algal genome
sequencing30 and in order to begin to explore the full metabolic
capability of Euglena, we have sequenced the transcriptome of
Euglena gracilis var. saccharophila. Transcriptomic approaches are
proving increasingly useful for illuminating the functional diversity
of microbial eukaryotic life, for instance in the oceans.31 Here we
present an initial analysis of Euglena transcriptomes obtained from
dark and light grown cells, with an emphasis on genes encoding
carbohydrate and natural products biochemistry, serving to illus-
trate the versatile metabolic capacity of this species.
Results and discussion
Nucleic acid extraction and transcript sequencing
To obtain a broad set of transcripts, RNA was extracted from
Euglena gracilis cells grown under two radically different growth
Fig. 1 The biology of Euglena gracilis. (A) Physiology of Euglena gracillis. (B) Phylogeny showing relationship between Euglena gracilis and sequenced
algae and model organisms.112 Organisms shown in green are photosynthetic.
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conditions. For autotrophic (photosynthetic) growth, cells were
cultured under ambient illumination on low nutrient media
solid agar, containing no amino acids or carbon source (referred
to as ‘‘light’’); high nutrient media liquid culture, containing
glucose and amino acids with no light source (referred to as
‘‘dark’’), was used to stimulate mixotrophic growth. Equal
amounts of mRNA from these two conditions were sequenced
using an Illumina HiSeq 2000 to give 26.5 Gb and 11.9 Gb of
good quality reads for light and dark grown cells, respectively
(Table 1). These sequences were assembled into contigs and
likely coding regions were predicted using the Trinity software
package.32 In this manner, 22 814 predicted protein-encoding
genes were identified in light-grown cells, while 26 738 were
evident in dark-grown cells, accounting for 32128 non-redundant
proteins predicted overall. This indicates that, depending on
growth conditions, there is a dramatic shift in metabolic capability.
Various eukaryotes splice a short leader sequence onto the
50 end of the mRNA, encoded from a different region of the
genome, to process the polycistronic transcripts and stabilise
the produced mRNAs.33 Previously a 26 nucleotide short leader
sequence had been identified in Euglena from 4 sequences,34
but this sequence was present ino1% of the transcripts presented
here. However a reduced 14 base sequence, ‘‘TCTATTTTTTTTCGA’’,
was present at the 50 UTR of 16.0% and 15.6% of the transcripts
from light and dark grown cells, though it is unclear how many
sequences without this modification are in fact full length, rather
than truncated by limitations of the sequencing.
In order to annotate gene functions, the 32 128 sequences
were compared to the UNiRef 100 database using BLASTP,
which produced 14 389 matches to proteins with annotated
functions.‡ The majority of transcript sequences identified
therefore show no match to any previously reported protein
sequence from any organism. Of the sequences that can be
annotated, 12 020 were classified into 157 Gene Ontology
classifications, covering the full spectrum of functions that
one might expect in a complex eukaryotic organism (Fig. 2).
The distribution of the top BLASTP hits shows a distribution
across the kingdoms of life, highlighting the diversity of
possible origins of genetic material present in the Euglena
genome, which have been integrated through its complex
phenotypic and genotypic history.27
Metabolism
Candidate genes were identified in the Euglena transcriptome
for all of the core metabolic pathways, including glycolysis and
gluconeogenesis, the citric acid cycle and the pentose phos-
phate pathway. There are also candidates for carotenoid and
thylakoid glycolipid biosynthesis, and the Calvin cycle, which
are required for photosynthesis. Reassuringly, the complete-
ness of these pathways confirms both adequate sequencing
depth and accurate functional assignments.
In addition to the expected candidates for fatty acid biosynthe-
sis, a capacity to produce isoprenoids, which have functions in
primary metabolism, is also evident in the Euglena transcriptome.
There are two pathways for the formation of the isoprenoid
precursor in plants: the cytosolic mevalonate (MVA)35 and the
plastidial methyl erythritol phosphate (MEP) pathway.36 Both
pathways are known in Euglena, although unusually the MEP
pathway only contributes to carotenoid biosynthesis and is not
involved in phytol synthesis.37 All enzymes for both pathways can
readily be identified in the transcriptome, with the exception of the
final decarboxylase of the MVA pathway (Fig. 3). The presence of
the rest of the pathway in Euglena implies this last reaction is likely
catalysed by a non-canonical enzyme. The initial and final enzymes
for the chloroplast-localised MEP pathway are only apparent in the
transcripts from dark grown cells, suggesting that under the
conditions utilised in this study, the MEP pathway is only active
in chloroplasts that are not supplying energy to the cells.
Euglena is self-contained in its amino acid requirements,
producing transcripts of all the obvious genes required for the
production of this class of molecule. Intriguingly, however,
Euglena appears to have acquired and retained genes for amino
acid biosynthesis that are reminiscent of both plant and bacterial
pathways. Moreover, it appears to duplicate functionality in
places: for aromatic amino acid biosynthesis, for instance, tran-
scripts for single function enzymes are evident alongside much
larger transcripts encoding several steps in the pathway (Fig. S1,
ESI†).27 The ability to produce multi-functional polydomain
proteins, arising from gene fusions, presents interesting oppor-
tunities from a synthetic biology perspective.
Carbohydrate-active enzymes
Euglena is not reported to have a carbohydrate-based cell wall
but it is known to utilise a b-1,3-glucan carbohydrate storage
Table 1 Summary of Euglena gracilis transcriptome
Light-grown cells Dark-grown cells Combined
Total number of reads 264 808 150 118 608 486 383 414 636
Total number of nucleotides 26.5 Gb 11.9 Gb 38.4 Gb
Total number of contigs 233 748 231 176
Median length of contigs 391 bp 364 bp
Total number of predicted ORFs longer than 100 aa 45 126 47 607 92 733
Number of unique proteins 22 814a 26 738a 32 128a
Mean length of unique proteins 456 aa 401 aa
a Non-redundant subsets derived with CD-HIT108 using identity threshold 0.95, word length 5.
‡ It should be noted that whilst some Euglena gracilis sequences already available
in the databases match the transcripts presented here, many do not. This is likely
due to the strains used in other studies not being related to the one used in the
present study: caution should be taken when comparing sequence data from
different algal isolates.
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polymer and it can become encased in a carbohydrate sheath,
forming cysts.38 Although the exact nature of the surface
glycan(s) is not known, it is thought to be highly complex,
containing glucose, galactose, mannose, fucose, xylose, rham-
nose and at least one hexosamine.39 The anticipated variety of
glycans and the metabolic versatility displayed by Euglenamake
this a potentially attractive organism in which to study carbo-
hydrate metabolism. This notion is supported by the wealth of
carbohydrate-active enzymes that are evident from transcrip-
tome data (Table 2).
With around 230 glycosyltransferases (GTs) (depending upon
the stringency used in annotation), Euglena is rich in GTs like
Homo sapiens or Caenorhabditis elegans and much richer than the
red alga Porphyridium purpureum, the green algae Micromonas sp,
the basal alga Cyanophora paradoxa, the cryptophyte Guillardia
theta and the chlorarachniophyte Bigelowiella natans (data from
the CAZy database40). Viridiplantae (‘green plants’) have signifi-
cantly more GTs than Euglena, and this is attributable to several
rounds of genome duplication. A repertoire of around 130 glycosyl
hydrolases, dominated by enzymes for the digestion of b-glucans
(vide infra), and very few different carbohydrate-binding modules
(CBMs), underlies a modest commitment to glycan digestion
which may reflect the photosynthetic nature of this organism,
which enables it to be largely self-sufficient in terms of carbo-
hydrate metabolism.
b-1,3-Glucan metabolism. The storage polysaccharide in
E. gracilis, paramylon, is composed of b-1,3-linked glucose,
rather than the more common a-1,4-linked glucan found in
plants, animals and bacteria. Paramylon is a crystalline granule
which is found in the cytosol, with characteristic shape dependent
upon the species of Euglena.41 These granules are synthesised by
transfer of glucose from UDP-glucose by paramylon synthase
(Fig. 4), a membrane bound 670 kDa complex composed of at
least 7 different proteins.42 Interestingly paramylon synthesis
appears to commence with the auto-glucosylation of a protein,
in a similar way to glycogen but not starch biosynthesis.43 In order
to identify the likely proteins involved in paramylon metabolism,
transcripts encoding potential b-glucan-active enzymes were
identified and annotated (Fig. 4).
Plants and fungi synthesise the b-1,3-glucans in their cell
walls using membrane-bound members of the GT48 family,
which may represent candidate paramylon synthases in
Euglena. Four sequences could be identified in the transcrip-
tome which encode candidate GT48 b-1,3-glucan synthases,
three of which are closely related to each other (94% identity).
These proteins are predicted to be around 300 kDa in size –
much larger than the proteins reported to make up the para-
mylon synthase complex,42 although proteolytic processing
cannot be ruled out. Enzymes of the GT2 family can also
participate in the biosynthesis of b-1,3- and b-1,4-glycans, such
as callose, chitin, and cellulose,40 and thus also represent
potential candidates for paramylon synthase. This family is
heavily represented in the Euglena transcriptome, with 16 unique
members, although few of these proteins has the QXXRW signa-
ture of processive polysaccharide synthases.44
Both endo- and exo-b-1,3-glucan hydrolases have been bio-
chemically identified in Euglena,45,46 and there are many glyco-
side hydrolases present in the Euglena transcriptome that
belong to the various GH families capable of degrading b-1,3-
glucans. There are transcripts encoding 17 members of family
Fig. 2 Assignment of transcripts. (A) Top 25 Gene Ontology terms assigned to the transcriptome. (B) Kingdom-level taxonomic distribution of top hits of
BLAST matches (E-values o 1  1010) of E. gracilis unique sequences.
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GH81, as well as three members of family GH17 and a single
member of family GH64, all families which contain endo-acting
hydrolases capable of cleaving in the middle of b-1,3-glucan
chains. These enzymes release short glucan chains which could
then be further degraded to glucose by b-glucosidases, for
which there are sequences for members of 6 families (GH1, 2,
3, 5, 30, 55) in the Euglena transcriptome. Alternatively, glucans
could be degraded by phosphorylases,47 releasing Glc-1-P.
b-1,3-Glucan phosphorylases have been well characterised in
Euglena48,49 and other unrelated algae,50 and have since been
identified in bacteria.51,52 The bacterial enzymes are in family
GH94 but exclusively act upon the disaccharide, laminaribiose.
No members of this family are present in the transcriptome,
suggesting Euglena utilises another enzyme family for this
activity.
Proteins and glycans. Protein glycosylation is one of the
hallmarks of eukaryotic cells, but has also been found in
some bacteria.53 The biosynthesis of asparagine-linked glycans
(N-glycans) proceeds by the synthesis of a lipid linked oligo-
saccharide precursor, which is transferred en bloc to proteins in
the lumen of the endoplasmic reticulum.54 Euglena has been
demonstrated to make the same precursor oligosaccharide as
animals and fungi (Glc3Man9GlcNAc2-Asn),
55 whilst the related
Trypanosomes have lost the ability to glucosylate the precursor
and Leishmania add two fewer mannose residues.56 Flagella-
associated glycoproteins in Euglena are affected by tunicamycin,
a known inhibitor of protein glycosylation,57 but the exact struc-
ture of the glycans and the identity of glycosylated proteins
Fig. 3 The isoprenoid biosynthetic pathways. There was no isoform for the final decarboxylase of the MEP pathway indicating an alternative enzyme
must be used in Euglena. In blue below each enzyme is the genus of the closest relative found for each isoform in the NCBI non-redundant protein
sequences collection, using BLASTP. The yellow boxes indicate the Euglena sequences could only be found in the transcriptome from dark grown cells;
red boxes indicate no homologues could be found in either the dark or light transcriptome.
Table 2 Annotation of carbohydrate active enzymes in Euglena
transcriptomea
Family Proteins Families
Glycosyl transferases (GTs) 229 34
Glycoside hydrolases (GHs) 126 26
Carbohydrate binding modules (CBM) 2 (+2 on GHs) 4
Carbohydrate esterases 9 2
a For a full breakdown of the carbohydrate active enzymes in Euglena
gracilis see http://www.cazy.org/eE.html.
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remain elusive. Sequences for all of the enzymes required for
synthesising the full Glc3Man9GlcNAc2 N-glycan precursor
are present in the Euglena transcriptome, along with three
sequences for the GT66 oligosaccharyltransferases that couple
the pre-formed oligosaccharide to proteins (Table S1, ESI†).
Euglena has a full complement of genes for the biosynthesis
of glycosylphosphatidylinositol (GPI) membrane anchors. This
is perhaps unsurprising for an organism that is phylogeneti-
cally related to the Trypanosomes, which make extensive use of
such glycolipids to attach proteins to their surface, (Table S2,
ESI†). However, this class of compounds remains to be identi-
fied and characterised in Euglena species; it is unclear whether
the prevalent use of GPI biochemistry in the parasitic protozoa,
with a need to rapidly alter their surface coat in order to evade
the host immune response, is replicated in their rather benign
water-borne relatives.
Xylose-containing polysaccharide metabolism. Although it
does not contain a classical plant-like polysaccharide cell wall,
it has been reported that Euglena has a complex xylose-
containing material associated with its flagella,58 the precise
structure of which has not been elucidated. A UDP-glucuronate
decarboxylase, responsible for the synthesis of the activated
xylose building block UDP-xylose, has been identified in Euglena
previously59 and there is one obvious transcript encoding this
enzyme in the Euglena transcriptome. Many enzymes related to
characterised xylosyltransferases are also represented in the tran-
scriptome, in particular 16 members of the GT61 (some of which
are only very distantly related to this family). There are transcripts
for 18 separate enzymes in family GT77 and two enzymes weakly
related to GT90 Enzymes in these families are typically associated
with plant cell wall biosynthesis and are predicted to be xylosyl- or
galactosyl-transferases. Three potential GH43 xylosidases/galacto-
sidases and a putative acetyl xylan esterase, whichmay be involved
in degradation or tailoring of xylan structures, are also encoded in
the transcriptome. Together this suggests that Euglena has the
capability of synthesising xylose-containing polysaccharides and
may either be able to degrade plant hemicellulose-related xylan or
to recycle its own xylose-containing glycans. The physiological
significance of these glycans is unknown, but it may be associated
with the assembly and stability of the complex architecture of the
flagella upon which Euglena depends for motility.
Glycoenzyme protein architecture. Many of the transcripts
identified in the present study represent alternative splicing
variants, information that would not be available from genome
sequencing. For example, transcripts lm.75841 and lm.75842
share an identical N-terminus coding for a family GT1 glycosyl-
transferase, but the former has a C-terminal extension, encoding
a peroxisomal protein, not present in the latter (Fig. 5A). The ratio
of the transcripts of the long to short isoforms was approximately
11 : 1 in the light sample, but in the dark no short sequence
variant is detectable. This suggests that in the light the enzyme
activity is required in both subcellular locations, but in the dark it
is not required in the cytosol. Euglena appears to make use of
alternative splicing to control subcellular targeting of a single
gene product, as has been seen for many enzymes,60 including
glycolytic enzymes in fungi61 and amino acid metabolic enzymes
in plants.62
Whilst fusion of CBMs to other CAZYs is relatively common
in nature, and contiguity of multiple glycoside hydrolase
domains in a single protein is well known, it is much rarer to
find glycosyltransferases in a protein containing other domains
with carbohydrate binding or enzyme activity.63 Two transcripts
Fig. 4 Enzymes proposed to be involved in paramylon biosynthesis. In Euglena paramylon is synthesised by glucosyl transfer from UDP-glucose, initially
onto a membrane bound protein,113 by a protein complex, forming strictly linear b-1,3-glucan chains which form intra chain triple helices. In plants and
fungi members of GT48 and GT2 are used to make b-1,3-glucans and members of both are present in the transcriptome. Paramylon is degraded by a
series of endo- and exo-b-glucosidases to form glucose,114 or by laminarin phosphorylase to form a-glucose-1-P.115 There are many members of
b-glucosidase families in the transcriptome but there is no member of GH94, the family to which the only sequenced laminaribiose phosphorylases
belong,51 suggesting a novel family for this activity in Euglena.
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were identified in the Euglena transcriptome that encode pro-
teins with more than one carbohydrate-active enzyme domain
(Fig. 5B). The first protein (lm.71174) has a putative GT11
fucosyltransferase domain, whose active site does not contain
the second arginine in the usual HxRRxD consensus motif,64
and a putative GT15 mannosyltransferase domain, which contains
the nucleophile and a zwitterionic ion binding motif (Fig. S2,
ESI†).65 A second two-domain protein (dm.47703) appears to have
a GT1 sugar transferase domain, most closely related to glucuronic
acid transferases,66 linked to a C-terminal GH78 a-rhamnosidase
domain.67 This protein might conceivably be involved in cleaving
rhamnose from a natural product and adding a glucuronic acid
moiety, which is known to facilitate sub-cellular relocalisation and
xenobiotic detoxification.68 Alternatively, it might be involved in
editing glycan sequences and structures. Further work is required
to assess these prospects.
Carbohydrate binding modules (CBMs) are typically found
as part of the same polypeptide sequence as carbohydrate-
active enzymes.69 There are 4 CBMs encoded in the Euglena
transcriptome (Fig. 5C), compared to 126 in Arabidopsis and 40
in humans.40 The other sequenced Euglenozoa, Trypanosoma
brucei and Leishmania braziliensis, only contain one CBM each,
although these organisms live in stable animal hosts and so do
not require complicated carbohydrate degradation mechan-
isms. The common conserved Euglenozoan CBM sits in family
48, typically associated with binding to glycogen, though
Euglena do not themselves produce or use glycogen. This
CBM is fused to the AMP-activated protein kinase beta sub-
unit,70 suggesting a phosphorylation-based regulatory role in
carbohydrate metabolism for this bifunctional protein. Euglena
also encodes a GH18 chitinase with a chitin-targeting CBM18,
with a potential function in the degradation of extracellular
chitin. A potential expansin for loosening plant cell wall glycan
architectures,71 fused to a cellulose-binding CBM63, is also
evident along with a single member of CBM57, a poorly charac-
terised protein family thought to bind N-glycans72 (Fig. 5C).
Vitamin C. Ascorbic acid is the most important antioxidant
in photosynthesising organisms, removing reactive oxygen
species using ascorbate peroxidase.73 In Euglena this enzyme
is localised in the cytosol, rather than the plastids, and has a
unique dimeric form.74 In general, ascorbic acid is synthesised
either via L-gulonolactone, as in animals,75 or by L-galactonate,
as in plants76 and green algae (Fig. 6).77 Euglena has been
proposed to contain a unique ascorbate biosynthesis pathway,
via L-galactonolactone.78 Radiotracer experiment show that,
although Euglena can form vitamin C from L-gulonolactone,
this L-galactonolactone pathway is dominant.79 More recently,
the galacturonate reductase was identified, characterised and
the N-terminal sequenced.80 The full-length transcript corre-
sponding to this sequence is most closely related to malate
dehydrogenase, highlighting the difficulty in correct functional
assignment based solely on bioinformatics. In the transcriptome
there is only one isoform of the aldonolactonase, which has been
cloned previously and shown to have activity on both L-gulonate
and L-galactonate.81 The remaining enzymes of ascorbate bio-
synthesis remain to be elucidated in this organism. In the
transcriptome presented here candidates are present for every
reaction in the biosynthesis of ascorbate, via L-gulonolactone,
L-galactose and L-galactonolactone. However several represent
weak assignments, particularly as prediction of sugar-based
substrates is notoriously difficult, and the major pathway for
the synthesis of ascorbate seems to be via L-galactonolactone.
Transcriptome information presented here may facilitate the
engineering of the various vitamin C pathways, either in
Euglena or in other organisms.
Small molecule redox regulators
Given the genetic commitment to the production or water-
soluble antioxidant vitamin C in Euglena, we were drawn to
consider how much broader this commitment to handling
redox stress might be. Euglena has long been known to produce
high levels of vitamin E,82 a lipid-soluble antioxidant (Fig. 7).83
Fig. 5 Domain structures of Euglena carbohydrate-active enzymes.
(A) Examples of splice variants in Euglena transcripts. lm.75841 (4.49) and
lm.75842 (3.01) are identical for the first 354 amino acids, comprising a GT1
domain, but lm.75841 has a further 421 amino acids, including a domain
related to Pex24p, an integral peroxisomal membrane protein. (B) Domain
architecture of didomain CAZys encoded in the Euglena transcriptome.
lm.71174 (0.90) encodes an N-terminal GT11 and a C-terminal GT15.
dm.47703 (3.61) encodes an N-terminal GT1 and a C-terminal GH78.
(C) Domain architectures of the four CBM containing sequences in
Euglena. CBM48 is characterised as binding a-1,4-glucans, and when
associated with this protein kinase domain, as in lm.25689 (29.61), is the
b-subunit of AMP-activated protein kinase. lm.29686 (15.02) contains a
chitin-binding CBM18 and a chitin degrading GH18. dm.80173 (3.10)
encodes a probable expansin and a cellulose directing CBM63.
lm.101413 (0.56) encodes a CBM57 with no other protein domains. FPKM
values in parentheses.
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This vitamin is synthesised from tyrosine and phytol; genes
encoding the key dioxygenase and homogentisate phytyl trans-
ferase are present in the transcriptome, along with strong
candidates for the rest of the pathway (Fig. S3, ESI†).
Whilst the tripeptide thiol glutathione (g-glutamyl-cysteinyl-
glycine) plays a significant redox-modulating role in most
eukaryotes and microorganisms, many bacteria and protozoa use
additional unusual thiol compounds.84 These includemycothiol in
actinobacteria,85 bacillithiol in some bacilli,86 and trypanothione
and ovothiol in trypanosomatids.87 Independent reductases with
exclusive activity towards either glutathione or trypanothione, have
previously been purified from E. gracilis,88 although the occurrence
of trypanothione has not been demonstrated in any Euglena. The
conjugation of glutathione to spermidine to form trypanothione is
carried out by either a two enzyme process (e.g. in Crithidia), with
the initial conjugation of glutathione to spermidine by gluta-
thionylspermidine synthase followed by addition of another gluta-
thione by trypanothione synthase,89 or by a single bifunctional
enzyme (e.g. in Trypanosoma).90 In the Euglena transcriptome, the
biosynthetic pathways for glutathione and spermidine are present
(Fig. S4, ESI†), and there are two gene sequences which more
closely match the trypanothione synthase than the glutathionyl-
spermidine synthase of Crithidia, although they are most closely
related to bacterial glutathionylspermidine synthases. It remains
to be established whether these enzymes each carry out a single
glutathione addition, or perform both conjugation steps.
With clear support for Euglena having a capacity to perform
trypanothione biochemistry, we sought to demonstrate the
presence of this thiol in Euglena extracts. HPLC analysis of
bromobimane-derivatised cell extracts clearly show peaks for
the ubiquitous glutathione and cysteine; there is also a small peak
co-eluting with trypanothione, (Fig. S5, ESI†). LC-MS revealed this
fraction contained both trypanothione and a compound with
a molecular weight 14 Da lower (Fig. S6, ESI†). MS2 analysis
revealed that this corresponds to a spermidine backbone that is
one carbon shorter than is usual in trypanothione, which suggests
the presence of the previously unreported nor-trypanothione
(Fig. 7). Euglena is known to make the nor-spermine and
nor-spermidine from 1,3-diaminopropane, which is thought
to be derived from diaminobutyric acid.91 This would require
some flexibility in the polyamine chain length in the trypano-
thione synthase, as is seen in T. cruzi, which makes homo-
trypanothione when supplied with exogenous cadavarine, one
carbon longer than spermidine.92
The only known enzyme for the biosynthesis of ovothiol
(Fig. 7) encodes a non-heme iron dioxygenase at the N-terminus
Fig. 6 Ascorbic acid biosynthesis. There are three pathways for the biosynthesis of ascorbate: the animal pathway (red arrows), the plant pathway (green
arrows) and the Euglena pathway (blue arrows). Candidate genes in the Euglena transcriptome are indicated with the genus of the closest homologue to
each isoform in blue. The Euglena aldonolactonase has been characterised in vitro and shown to act on both L-gulonate and L-galactonate.
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and an N-methyl transferase at the C-terminus, capable of
effecting oxidative C–S bond formation, sulfoxidation and
N-methylation (Fig. S4, ESI†).93 In the Euglena transcriptome,
there is one sequence related to the N-terminus and one related
to the C-terminus in both dark and light transcript sets, and a
single transcript coding for both domains found only in the
dark grown cells. A small peak eluting in the correct region of
the HPLC,87 with consistent MS fragmentation, suggests that
ovothiol is indeed present in Euglena (Fig. S5 and S6, ESI†).
Given the prevalence of thiol biochemistry in Euglena, and
the central role that ovothiol-related compounds (ergothio-
neine) have recently been shown to have in biosynthesis of
the antibiotic lincomycin,94 we were drawn to evaluate the
capacity of E. gracilis for coenzyme A/acyl carrier protein-
dependent processes, such as those that are often central to
natural product biosynthesis. No polyketides or non-ribosomal
peptides have been confirmed in Euglena to date, but there are
transcripts apparent for the complex secondary metabolite
synthases needed to make such compounds, as is evident for
an increasing array of algae now that genome/transcriptome
sequence data is becoming available.95
Polyketides
Polyketides comprise a huge range of compounds, formed by
repeated condensation of acetate units, followed by variable
reduction and further elaboration. Broadly speaking polyketide
synthases (PKSs) can be large multidomain proteins (type I) or
composed of discrete proteins with individual functions (type II),
although there are other architectures possible.96 Only one
possible polyketide, the alkaloid euglenophycin (Fig. 7), has been
isolated and characterised from a Euglena (Euglena sanguinea),
based on its toxicity to fish.97 However, using the established
isolation methods,98 we could find no evidence for the produc-
tion of this compound by E. gracilis.
To identify polyketide synthases the proteome was searched
for ketosynthases, the key catalytic domain, using BLASTP.99
Fourteen potential PKSs were identified as having this domain
(Table S3, ESI†): six sequences encode multiple domains indi-
cative of type I PKSs; three sequences encode one catalytic
domain and an acyl carrier protein domain; one sequence
carries two catalytic domains; four sequences only encode
individual domains. The latter may be true type II PKS modules,
or fragments of type I caused by failure to assemble full length
transcripts. They may also be enzymes with other functions that
this search technique reveals, such as fatty acid synthases. The
poor Kozak consensus and lack of upstream stop codons indicate
these genes could encode fragments of longer proteins.
Attempts to predict the structures of the compounds synthe-
sised by these putative Euglena PKS enzymes, based on domain
architectures, using SBSPKS100 and the PKS/NRPS Analysis
Web-site,101 were not successful. This is probably due to the
evolutionary distance from the bacterial and fungal species
these pieces of software were designed to deal with. Analysis of
the domain sequences of these enzymes using DELTA-BLAST,
has allowed some assessment of the production line-like
machinery and the products that could be made (Fig. 8). For
example, in addition to a fully reducing PKS module, the largest
polyketide synthase encoded in the Euglena transcriptome
contains two enoyl hydratases and an HMGCoA synthase. As
single domain proteins, these have been characterised in bacterial
gene clusters as adding a b-methyl branch to polyketides such
as bacillaene.102 This novel domain architecture suggests the
formation of an alkane followed by addition of a b-methyl branch.
Thus, although Euglena is not known to make polyketides, there
is apparent capacity for the synthesis of complex natural products
of this type.
Non-ribosomal peptides
Non-ribosomal peptide synthetases (NRPSs) are multi-domain
proteins that join amino acids together to form small mole-
cules with a diversity of function, including siderophores, such
as enterobactin.103,104 No non-ribosomal peptides have been
isolated from Euglenoids, but in the E. gracilis transcriptome,
19 putative NRPSs can be recognised based on the presence of
the adenylation (A) domain and 16 based on the condensation
(C) domain (Table S3, ESI†). This search strategy reveals many
sequences that are most closely related to enzymes involved inFig. 7 Antioxidants and natural products produced by Euglena species.
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fatty acid biosynthesis and two transcripts for L-aminoadipate-
semialdehyde dehydrogenase, involved in lysine biosynthesis.
Five transcripts encode proteins with both an A and a C domain
(Fig. 8), and the remainder have either only an A or only a C
domain. Notably, three adenylation domain-encoding tran-
scripts also have ankyrin domains, potentially involved in
protein–protein interactions,105 which may imply formation
of non-covalent assemblies of NRPS modules. The function
prediction programs, SBSPKS100 and NRPS/PKS Analysis Web-
site,101 were unable to predict structure from these sequences.
However, given the ability of E. gracilis to actively uptake iron
from growth medium (Fig. S7, ESI†), it may be reasonable to
speculate that Euglena use NRPSs to produce peptide-based
siderophores, a well-known strategy amongst the bacteria.106
Conclusions and outlook
Euglena gracilis has been a mainstay of 20th century biology
because of its ease of culture, large cell size and metabolic
diversity. It is now evident that a combination of protozoan,
animal, plant, fungal and prokaryotic genes contribute to its
transcriptome, highlighting the evolutionary complexity of this
unicellular alga. The wide range of metabolites in Euglena is a
function of this evolutionary history, while sequences for
enzymes involved in biosynthetic pathways not previously
identified in Euglena suggests that we have barely scratched
the surface of the metabolic potential of this class of organism.
Although its chloroplast genome, a prokaryote-like plasmid,
was sequenced in 1993,107 Euglena has lagged behind as
attention has largely focused on a limited number of model
organisms. With the cost of nucleic acid sequencing decreasing
rapidly, the opportunity to widen the repertoire of study organisms
is considerable. The transcriptome dataset reported herein brings
Euglena into the post genomic era and should facilitate the
exploitation of this powerful bioresource, hopefully also stimu-
lating wider consideration of microalgae as vehicles for natural
products chemistry and synthetic biology.
Experimental
E. gracilis cell culture
Euglena gracilis var. saccharophila Klebs (strain 1224/7a) was
obtained from the Culture Collection of Algae and Protozoa
(http://www.ccap.ac.uk/).
High nutrient media. For culture in the dark, cells were
grown in the recommended 1X EG + 1X JM media (Euglena
gracilis medium plus Jaworski’s Medium, replacing ‘‘Lab-
Lemco’’ with Tryptone), supplemented with 15 g L1 glucose,
at 30 1C and shaken at 200 rpm in the dark, for 7 days between
sub-culturing. Dark grown cells were harvested by centrifuga-
tion at 800g for 10 min, with rapid decantation of the super-
natant to avoid redistribution of the motile cells.
Low nutrient media. For culturing cells autotrophically, the
media was adjusted to contain no amino acids or sugars as
energy source. The medium consisted of CaCl2 (0.1 g L
1),
NaOAc(H2O)3 (1 g L1) and JM containing 15 g L1 agar.
Cultures were grown at 21 1C under ambient light and grew
extremely slowly, taking 4 weeks between sub culturing. Light
grown cells were collected by pipetting 1 ml Milli-Q H2O to
resuspend cells from the agar plate.
RNA extraction, sequencing and bioinformatics
Total RNA was isolated from 106 dark and light grown cells
using RNeasy Minikit (Qiagen) and stored at 80 1C. Source
Bioscience (Nottingham, UK) then performed mRNA purifica-
tion, library preparation and sequencing on an Illumina HiSeq
2000 platform. A total of 313 205 944 and 137 689 062 100-base,
paired-end reads were obtained from the light- and dark-grown
samples respectively. The light-grown sequence data, down-
sampled to 100 million pairs of reads, and the entire dataset of
68844531 read-pairs from the dark-grown sample were used for
separate de novo assemblies using Trinity30 version r2013-02-25,
executed in parallel on two 256 GB cluster nodes. 233748 and
231176 raw assemblies were generated from light and dark respec-
tively. Likely coding sequences were extracted from these reads
using the Perl utility script supplied with the Trinity distribution,
transcripts_to_best_scoring_ORFs.pl, producing 45126 and 47607
candidate ORFs of lengths greater than 100 amino acids. Putative
coding sequences were combined and a non-redundant set of
32128 peptides produced using CD-HIT108 (v4.5.4) with an identity
threshold of 0.95 and a word length of 5. For functional annotation,
the set was queried against the UniRef 100 protein database using
BLASTP with an E-value threshold of 1 1010. Sequence identifiers
of the best hits were harvested and used to programmatically collect
from databases, via SOAP-based web services, GO terms and KEGG
pathway objects, and also used to enumerate kingdom-level taxo-
nomic classifications for the species of origin. Transcript levels for
isoforms were estimated from the reads using the RSEM wrapper
script supplied in the Trinity distribution to implement the RNA-Seq
by Expectation Maximisation methods.109
Annotation of carbohydrate-active enzymes (CAZys)
Putative carbohydrate-active enzymes were identified and classi-
fied using the methods used for updating the carbohydrate-active
Fig. 8 Natural product synthases. Domain architectures of three candi-
date polyketide synthases and non-ribosomal peptide synthases from
Euglena. Domains were identified using the Conserved Domain Database.
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enzymes database (CAZy; www.cazy.org) as described previously.40
Briefly, the translated protein sequences of Euglena were com-
pared to the full-length sequences derived from CAZy using
BLAST.110 The sequences that gave an E-value o 0.1 were then
subjected to a second BLAST search against a library made with
the constitutive modules of glycoside hydrolases (GH), glycosyl-
transferases (GT), polysaccharide lyases (PL) and carbohydrate
esterases (CE) and their associated carbohydrate-binding (CBM)
modules. In parallel the sequences were subjected to a HMMer
search using hidden Markov models built for each CAZy module
family.111 A protein was considered reliably assigned when it was
placed in the same family by the two methods. No particular
E-value threshold was used as the E-value varies extensively with
the length of the aligned sequences. Instead we relied on manual
curation and examination of conserved features such as catalytic
residues. Difficult cases were resolved by manual inspection of
conserved features such as catalytic residues.
Identification of thiols
Cells grown in the high nutrient media, at 21 1C with ambient
light, were collected by centrifugation at 13 000 rpm, flash
cooled in liquid nitrogen and stored at 80 1C until analysis.
20 mg of cells were extracted into 50% acetonitrile at 60 1C and
the thiols were labelled with monobromobimane (Invitrogen)
and separated on an ACE AR C18 4.6 250 mm, 5 mm (HiChrom)
by HPLC (JASCO) with fluorescence detection (JASCO FP2020
Plus) with excitation at 385 nm and emission at 460 nm. The
gradient used started from 0.225% aqueous acetic acid, pH 4.0 to
100% 90% aqueous methanol over 50 min, hold for 2 min,
reduced to 0% in 2 min and hold for 10 min with a flow rate of
1 ml min1.85 Fluorescent peaks were collected and further
analysed by LC-MS using a Surveyor HPLC attached to a DecaXP-
plus ion trap MS (Thermo). Separation was on a Kinetex XB-C18
50  2.1 mm, 2.6 mm column (Phenomenex) running the follow-
ing gradient of acetonitrile (B) versus 0.1% formic acid in water (A)
at 300 mL min1 and 30 1C: 0 min, 2% B; 10 min, 30% B; 20 min,
95% B; 22 min, 95% B; 22.5 min, 2% B; 26 min, 2% B. Bimane-
labelled thiols were detected by UV at 390 nm, and positive
electrospray MS. MS spectra were collected from m/z 250–2000
and MS2 spectra of the most abundant ions were collected at an
isolation width of m/z 4.0 and 35% collision energy. Spray
chamber conditions were 50 units sheath gas, 5 units aux gas,
350 1C capillary temperature, and a spray voltage of 3.8 kV using a
steel needle kit.
Accession codes
Sequence reads were deposited in the Sequence Read Archive
under submission number PRJEB10085.
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